vs

Side-by-side financial comparison of Core Laboratories Inc. (CLB) and Regional Management Corp. (RM). Click either name above to swap in a different company.

Regional Management Corp. is the larger business by last-quarter revenue ($167.3M vs $121.8M, roughly 1.4× Core Laboratories Inc.). Regional Management Corp. runs the higher net margin — 6.8% vs 4.2%, a 2.6% gap on every dollar of revenue. On growth, Regional Management Corp. posted the faster year-over-year revenue change (9.4% vs -1.4%). Over the past eight quarters, Regional Management Corp.'s revenue compounded faster (8.2% CAGR vs -3.4%).

Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices.

Millennium Management LLC is an investment management firm with a multistrategy hedge fund offering. It is one of the world's largest alternative asset management firms with $83.4 billion assets under management as of January 2026. The firm operates in America, Europe and Asia. As of 2022, Millennium had posted the fourth highest net gains of any hedge fund since its inception in 1989.

CLB vs RM — Head-to-Head

Bigger by revenue
RM
RM
1.4× larger
RM
$167.3M
$121.8M
CLB
Growing faster (revenue YoY)
RM
RM
+10.8% gap
RM
9.4%
-1.4%
CLB
Higher net margin
RM
RM
2.6% more per $
RM
6.8%
4.2%
CLB
Faster 2-yr revenue CAGR
RM
RM
Annualised
RM
8.2%
-3.4%
CLB

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
CLB
CLB
RM
RM
Revenue
$121.8M
$167.3M
Net Profit
$5.1M
$11.4M
Gross Margin
Operating Margin
1.5%
Net Margin
4.2%
6.8%
Revenue YoY
-1.4%
9.4%
Net Profit YoY
62.7%
EPS (diluted)
$0.11
$1.18

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLB
CLB
RM
RM
Q1 26
$121.8M
$167.3M
Q4 25
$138.3M
$169.7M
Q3 25
$134.5M
$165.5M
Q2 25
$130.2M
$157.4M
Q1 25
$123.6M
$153.0M
Q4 24
$129.2M
$154.8M
Q3 24
$134.4M
$146.3M
Q2 24
$130.6M
$143.0M
Net Profit
CLB
CLB
RM
RM
Q1 26
$5.1M
$11.4M
Q4 25
$4.9M
$12.9M
Q3 25
$14.2M
$14.4M
Q2 25
$10.6M
$10.1M
Q1 25
$-154.0K
$7.0M
Q4 24
$7.4M
$9.9M
Q3 24
$11.7M
$7.7M
Q2 24
$9.0M
$8.4M
Gross Margin
CLB
CLB
RM
RM
Q1 26
Q4 25
20.8%
Q3 25
22.0%
Q2 25
20.3%
Q1 25
19.5%
Q4 24
17.8%
Q3 24
20.5%
Q2 24
21.2%
Operating Margin
CLB
CLB
RM
RM
Q1 26
1.5%
Q4 25
11.5%
9.5%
Q3 25
15.6%
11.5%
Q2 25
11.7%
8.6%
Q1 25
3.6%
6.0%
Q4 24
11.0%
8.2%
Q3 24
14.7%
6.9%
Q2 24
12.3%
7.8%
Net Margin
CLB
CLB
RM
RM
Q1 26
4.2%
6.8%
Q4 25
3.6%
7.6%
Q3 25
10.6%
8.7%
Q2 25
8.2%
6.4%
Q1 25
-0.1%
4.6%
Q4 24
5.7%
6.4%
Q3 24
8.7%
5.2%
Q2 24
6.9%
5.9%
EPS (diluted)
CLB
CLB
RM
RM
Q1 26
$0.11
$1.18
Q4 25
$0.11
$1.30
Q3 25
$0.30
$1.42
Q2 25
$0.22
$1.03
Q1 25
$0.00
$0.70
Q4 24
$0.15
$0.96
Q3 24
$0.25
$0.76
Q2 24
$0.19
$0.86

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLB
CLB
RM
RM
Cash + ST InvestmentsLiquidity on hand
$22.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$275.1M
$375.8M
Total Assets
$587.7M
$2.1B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLB
CLB
RM
RM
Q1 26
$22.8M
Q4 25
$22.7M
Q3 25
$25.6M
Q2 25
$31.2M
Q1 25
$22.1M
Q4 24
$19.2M
Q3 24
$21.5M
Q2 24
$17.7M
Total Debt
CLB
CLB
RM
RM
Q1 26
Q4 25
$110.3M
$1.6B
Q3 25
$114.1M
$1.6B
Q2 25
$124.6M
$1.5B
Q1 25
$124.4M
$1.5B
Q4 24
$126.1M
$1.5B
Q3 24
$139.9M
$1.4B
Q2 24
$147.6M
$1.4B
Stockholders' Equity
CLB
CLB
RM
RM
Q1 26
$275.1M
$375.8M
Q4 25
$266.0M
$373.1M
Q3 25
$271.3M
$371.9M
Q2 25
$261.3M
$363.0M
Q1 25
$253.4M
$357.9M
Q4 24
$246.6M
$357.1M
Q3 24
$250.7M
$352.9M
Q2 24
$240.3M
$344.9M
Total Assets
CLB
CLB
RM
RM
Q1 26
$587.7M
$2.1B
Q4 25
$584.0M
$2.1B
Q3 25
$591.4M
$2.0B
Q2 25
$602.1M
$2.0B
Q1 25
$591.5M
$1.9B
Q4 24
$585.1M
$1.9B
Q3 24
$600.5M
$1.8B
Q2 24
$597.8M
$1.8B
Debt / Equity
CLB
CLB
RM
RM
Q1 26
Q4 25
0.41×
4.40×
Q3 25
0.42×
4.23×
Q2 25
0.48×
4.14×
Q1 25
0.49×
4.11×
Q4 24
0.51×
4.12×
Q3 24
0.56×
3.94×
Q2 24
0.61×
3.98×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLB
CLB
RM
RM
Operating Cash FlowLast quarter
$4.0M
Free Cash FlowOCF − Capex
$517.0K
FCF MarginFCF / Revenue
0.4%
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
0.77×
TTM Free Cash FlowTrailing 4 quarters
$22.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLB
CLB
RM
RM
Q1 26
$4.0M
Q4 25
$7.9M
$309.1M
Q3 25
$8.5M
$86.7M
Q2 25
$13.9M
$78.7M
Q1 25
$6.7M
$63.7M
Q4 24
$20.6M
$268.9M
Q3 24
$13.1M
$75.1M
Q2 24
$17.1M
$71.5M
Free Cash Flow
CLB
CLB
RM
RM
Q1 26
$517.0K
Q4 25
$5.0M
$304.3M
Q3 25
$6.5M
$85.7M
Q2 25
$10.4M
$77.6M
Q1 25
$3.9M
$62.4M
Q4 24
$17.4M
$263.9M
Q3 24
$10.4M
$73.8M
Q2 24
$14.3M
$70.3M
FCF Margin
CLB
CLB
RM
RM
Q1 26
0.4%
Q4 25
3.6%
179.3%
Q3 25
4.8%
51.8%
Q2 25
8.0%
49.3%
Q1 25
3.1%
40.8%
Q4 24
13.4%
170.4%
Q3 24
7.7%
50.4%
Q2 24
10.9%
49.1%
Capex Intensity
CLB
CLB
RM
RM
Q1 26
Q4 25
2.1%
2.8%
Q3 25
1.5%
0.6%
Q2 25
2.7%
0.6%
Q1 25
2.3%
0.8%
Q4 24
2.5%
3.3%
Q3 24
2.0%
0.9%
Q2 24
2.2%
0.8%
Cash Conversion
CLB
CLB
RM
RM
Q1 26
0.77×
Q4 25
1.61×
23.94×
Q3 25
0.60×
6.04×
Q2 25
1.31×
7.76×
Q1 25
9.09×
Q4 24
2.78×
27.13×
Q3 24
1.12×
9.80×
Q2 24
1.90×
8.47×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons